Trial Details
COMPLETEDBasic Information
| Clinical ID | c2292 |
|---|---|
| Identifier | NCT03721107 |
| Trial Title | A Trial for New Treatment of Adult Participants With Irritable Bowel Syndrome |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Irritable Bowel Syndrome |
| Interventions | BIOLOGICAL: Blautix|OTHER: Placebo |
Participant Information
| Sponsor | 4D pharma plc |
|---|---|
| City | Huntsville |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2018-10-11 |
|---|---|
| Primary Completion Date | 2020-05-13 |
| Completion Date | 2020-05-13 |